Search Results - BC Cancer Agency Library

Cellular and molecular immunology

https://bccalibrary.andornot.com/en/permalink/catalog123118

Abbas, Abul K., Lichtman, Andrew H., Pillai, Shiv. Philadelphia, PA: Elsevier Inc. , [2022]. 10th ed.

Audience: Professional

Call Number: QW568 A122c 2022

Availability: 1 copy, 1 available

Contents:; Properties and Overview of Immune Responses -- Cells and Tissues of the Immune System -- Leukocyte Circulation and Migration into Tissues -- Innate Immunity -- Antibodies and Antigens -- Antigen Presentation to T Lymphocytes and the Functions of MHC Molecules -- Immune Receptors and Sign…

Author: Abbas, Abul K.; Lichtman, Andrew H.; Pillai, Shiv

Edition: 10th ed.

Place of Publication: Philadelphia, PA

Publisher: Elsevier Inc.

Publication Date: [2022]

Physical Description: xii, 587 p. : col. ill. : 28 cm.

Subjects: Immunity, Cellular; Antibody Formation - immunology; Antigens - immunology; Immunologic Diseases - immunology; Lymphocytes - immunology

Abstract: Contents:; Properties and Overview of Immune Responses -- Cells and Tissues of the Immune System -- Leukocyte Circulation and Migration into Tissues -- Innate Immunity -- Antibodies and Antigens -- Antigen Presentation to T Lymphocytes and the Functions of MHC Molecules -- Immune Receptors and Signal Transduction -- Lymphocyte Development and Antigen Receptor Gene Rearrangement -- Activation of T Lymphocytes -- Differentiation and Functions of CD4+ Effector T Cells -- Differentiation and Functions of CD8+ Effector T Cells -- B Cell Activation and Antibody Production -- Effector Mechanisms of Humoral Immunity -- Specialized Immunity at Epithelial Barriers and in Immune Privileged Tissues -- Immunologic Tolerance and Autoimmunity -- Immunity to Microbes -- Transplantation Immunology -- Immunity to Tumors -- Hypersensitivity Disorders -- Allergy -- Congenital and Acquired Immunodeficiencies

ISBN: 9780323757485

Language: English

Material Type: Book

Audience: Professional

Location: Vancouver Library

Call Number: QW568 A122c 2022

Copies

c.1 BC Cancer Agency VAN Library

Available

Characterization and cDNA cloning of a novel Murine T cell surface antigen YE1/48

https://bccalibrary.andornot.com/en/permalink/catalog8166

Chan, Po-Ying. [Vancouver, BC?]: University of British Columbia , 1988.

Audience: Professional

Call Number: WH250 C454 1988

Availability: 1 copy, 1 available

Author: Chan, Po-Ying

Place of Publication: [Vancouver, BC?]

Publisher: University of British Columbia

Publication Date: 1988

Subjects: DNA; Antigens, Differentiation, T Lymphocyte; Antigens, Surface; Cloning, Molecular

Language: English

Material Type: Book; Thesis

Audience: Professional

Location: Vancouver Library

Call Number: WH250 C454 1988

Copies

c.1 BC Cancer Agency VAN Library

Available

Characterizing the regulation of RasGRP1 and CalDAG1 : two C1 domain-containing ras guanine necleotide exchange factors

https://bccalibrary.andornot.com/en/permalink/catalog18632

Anthony, Kira. [Vancouver, BC?]: University of British Columbia , 2002.

Audience: Professional

Call Number: LE3 2002 A628

Availability: 1 copy, 1 available

Author: Anthony, Kira

Place of Publication: [Vancouver, BC?]

Publisher: University of British Columbia

Publication Date: 2002

Subjects: RASGRP1 protein, human; ras Guanine Nucleotide Exchange Factors; Guanine Nucleotide Exchange Factors

Language: English

Material Type: Book; Thesis

Audience: Professional

Location: Vancouver Library

Call Number: LE3 2002 A628

Copies

c.1 BC Cancer Agency VAN Library

Available

Charting a course : refining Canada's approach to regulating natural health products

https://bccalibrary.andornot.com/en/permalink/catalog15555

National Health Products Directorate, Health Products and Food Branch. , 2007.

Audience: Professional

3 read online

Corporate Author: National Health Products Directorate, Health Products and Food Branch

Publication Date: 2007

Subjects: Drug Industry - legislation & jurisprudence; Biological Products; Consumer Product Safety - legislation & jurisprudence; Dietary Supplements - standards; Government Regulations; Health Food; Legislation, Food; Canada

ISBN: 9780662453857

Language: English

Material Type: Book; Online

Audience: Professional

Location: Internet

Read Online

http://www.hc-sc.gc.ca/ahc-asc/alt_formats/hpfb-dgpsa/pdf/hpfb-dgpsa/chart-course_tracer-voie-eng.pdf

http://www.hc-sc.gc.ca/ahc-asc/branch-dirgen/hpfb-dgpsa/blueprint-plan/chart-course_tracer-voie_e.html

http://www.hc-sc.gc.ca/ahc-asc/branch-dirgen/hpfb-dgpsa/blueprint-plan/chart-course_tracer-voie-eng.php

Chimeric antigen receptor t-cell therapies for cancer : a practical guide

https://bccalibrary.andornot.com/en/permalink/catalog122174

Cambridge, MA: Elsevier, Inc. , 2020.

Audience: Professional

Call Number: QZ266 C538 2020

Availability: 3 copies, 3 available

Contents:; Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients r…

Editor: Lee, Daniel W.; Shah, Nirali N.

Place of Publication: Cambridge, MA

Publisher: Elsevier, Inc.

Publication Date: 2020

Physical Description: xiv, 229 p. : ill. ; 24 cm.

Subjects: Neoplasms - therapy; Receptors, Chimeric Antigen - therapeutic use; Receptors, Antigen, T-Cell; Immunotherapy, Adoptive - methods; Cell- and Tissue-Based Therapy

Abstract: Contents:; Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients receiving CAR therapy -- Neurotoxicities after CAR-T cell immunotherapy -- Hematologic and non-CRS toxicities -- Response assessment and post-CAR-T cell therapy management -- Relapse management and role for consolidative hematopoietic stem cell transplantation following CAR-T cell therapy -- Promising chimeric antigen receptors for non-B cell hematological malignancies, pediatric solid tumors, and carcinomas -- CAR T cell therapy for CNS malignancies -- CAR 2.0: the next generation of synthetic receptor-based cellular therapy for cancer.